What is Melasyl™?

Melasyl™, scientifically known as 2-mercaptonicotinoyl glycine (Melasyl), is a proprietary cosmetic ingredient developed and patented by L'Oréal Research. With 121 scientific studies underpinning its development, this breakthrough molecule is recognized for its significant role in addressing localized hyperpigmentation and enhancing skin tone uniformity across all skin tones.*

A Revolutionary Mechanism of Action

What makes Melasyl™ truly groundbreaking is how fundamentally different it is from every other brightening ingredient you've encountered. To understand why this matters, you need to understand how dark spots form—and how traditional ingredients attempt to stop them.

The Traditional Approach: Tyrosinase Inhibitors

For decades, brightening ingredients like Vitamin C, kojic acid, and arbutin have worked by inhibiting tyrosinase—the enzyme responsible for melanin production. While effective, this approach has limitations because it only partially addresses the pigmentation process. *

The Melasyl™ Innovation: Melanin Precursor Interception

Melasyl™ takes an entirely different approach. Rather than inhibiting tyrosinase, it intercepts an excess of melanin precursors before they mark the skin. These precursors are uncolored molecules that, through enzymatic reactions, would eventually transform into colored melanin pigments (eumelanin or pheomelanin).*

Here's how it works: Melasyl™ binds with melanin precursor —specifically, dopaquinone, DHICA-quinone, and DHI-quinone. By binding to these precursors, Melasyl™ prevents their integration into growing melanin, thereby inhibiting excessive melanin accumulation and preventing hyperpigmentation. * This specific intervention occurs at an early stage in the melanin production pathway, making it an innovative approach to skin pigmentation management. *

Think of it this way: if melanin production is a factory assembly line, traditional ingredients try to shut down the machinery (tyrosinase enzyme). Melasyl™ intercepts the raw materials before they enter the last stage of the assembly line—stopping dark spots before they mark the skin.

The Chemical Structure That Makes It Work

Melasyl™ possesses a unique chemical structure characterized by a specific backbone. * This specific structure is what allows it to effectively bind to melanin precursors like dopaquinone, forming stable conjugates. *

Research conducted in laboratory settings demonstrated this binding mechanism clearly. In cell cultures of melanocytes—the specialized pigment-producing cells in your skin—scientists observed the formation of 6-MNG-DOPA conjugates. When they increased the precursor to melani in the culture medium, this binding was enhanced further, supporting the hypothesis that Melasyl™ intercepts melanin precursors at their source. *

The path to Melasyl™ represents one of the most advanced research programs in cosmetic science history.

35 Years of Pigmentation Research

L'Oréal Research has been dedicated to studying skin pigmentation for over 35 years, with initial efforts dating back to 1996 focused on developing models of pigmented reconstructed skin.* This decades-long commitment laid the foundation for understanding the complex mechanisms of melanin production across diverse skin tones.

Screening 100,000 Molecules

The discovery of Melasyl™ emerged from a comprehensive research program involving the high-throughput screening of over 100,000 molecules.* This wasn't random testing—it was a sophisticated approach combining physicochemical properties, environmental profile, performance, and safety considerations to identify chemicals with a specific backbone as potent brightening agents.*

Among these 100,000 candidates, Melasyl was identified as the most promising due to its optimal balance of efficacy, safety, and respect for diversity.* The first molecule of this chemical type was identified in 2008, and the family including Melasyl™ was patented in 2010. The first specific patent for Melasyl™ was issued in 2015, with a total of 23 patents filed globally to protect this innovation.*

Why This Discovery Matters

The significance of Melasyl™ extends far beyond scientific achievement. As Anne Colonna, Global Head of Advanced Research at L'Oréal Groupe, stated: "Half of all people report having skin pigmentation issues and a third of these experiencing lower quality of life as a result, the impact of visible spots is clearly more than skin-deep."*

This underscores why finding a truly effective, safe, and inclusive solution for hyperpigmentation and, in particular, dark spots represents such a meaningful breakthrough for millions of people worldwide.

Extensive clinical testing validates Melasyl™'s efficacy across diverse environments and women with diverse skin tones.

Laboratory and Clinical Validation

The efficacy of Melasyl™ has been thoroughly investigated through in vitro skin models, ex vivo studies, and in vivo studies involving thousands of women, spanning years of research. *

Double-Blind, Randomized Clinical Studies

Clinical studies tested formulations containing 0.5% and 1% Melasyl against a vehicle control. These rigorous studies demonstrated that Melasyl™ could prevent UV-induced immediate skin darkening and inhibit delayed tanning without adverse effects.*

Superior to 10+ Leading Actives

A meta-analysis indicated that 0.5% Melasyl™ provided statistically superior anti-pigmentation performance compared to a range of more than ten other recognized actives from the market, including Vitamin C, kojic acid, niacinamide, and arbutin tranexamic.* This head-to-head comparison proves Melasyl™'s exceptional efficacy against the gold standards of brightening science.

Effective Across All Skin Tones

One of Melasyl™'s most impressive achievements is its proven efficacy across the full Fitzpatrick scale—phototypes I through VI, from very fair to very dark skin.*

Study on Phototypes III-V

In a 3-month clinical study on Asian volunteers (Fitzpatrick scale Phototypes IV & V) and Chinese volunteers (Fitzpatrick scale Phototypes III), Melasyl™ 0.5% visibly decreased Ultraviolet-induced pigmentation by intercepting and delaying melanin formation.* This demonstrates effectiveness on medium to darker skin tones, where hyperpigmentation is often most visible and most stubborn.

Universal Application

The mechanism of action—intercepting melanin precursors—works identically regardless of natural skin tone. Whether you have fair skin prone to sun spots or a deeper skin tone experiencing post-inflammatory hyperpigmentation, Melasyl™ targets the same pigmentation pathway with proven results and tolerance.

L'Oréal Paris incorporated this breakthrough ingredient into pioneering, effective formulations designed to make Melasyl™ widely available to consumers worldwide.*

The Revolutionary Formula

Revitalift Laser Melasyl Creamy-Serum combines Melasyl™ with complementary brightening actives for triple-action correction of dark spots, wrinkles, and dullness.

Daily dosage of Derm-Grade Actives:

• Melasyl™ (2-Mercaptonicotinoyl Glycine): Intercepts melanin precursors before they mark the skin
• Niacinamide: Reduces melanin transfer by 78% and regulates melanin overproduction*
• Ascorbyl Glucoside (Vitamin Cg): Stable Vitamin C derivative for brightening and antioxidant defense
• Capryloyl Salicylic Acid (LHA): Gentle chemical exfoliation helps accelerate the removal of pigmented cells
• Hydroxyethylpiperazine Ethane Sulfonic Acid (HEPES): Refines skin texture for improved radiance through a biochemical peeling process
• Dipotassium Glycyrrhizate (Licorice Root Extract): Anti-inflammatory properties calm irritation
• Glycerin: Provides 100-hour hydration for optimal skin barrier function to reinforce the natural protective strength against aggressive penetration of environmental pollutants

Why This Combination Works

The synergy between Melasyl™, Niacinamide, and Vitamin C creates multi-mechanism brightening that addresses hyperpigmentation at every stage:

Stage 1 - Prevention: Vitamin C neutralizes free radicals from UV and pollution before they trigger melanocytes. Niacinamide's anti-inflammatory properties reduce triggers for post-inflammatory hyperpigmentation.*

Stage 2 - Interception: Melasyl™ captures melanin precursors before they become a dark spot, stopping the process at its earliest formation point.

Stage 3 - Transfer slowdown: Niacinamide slows down melanin transfer from melanocytes to surrounding skin cells, preventing pigment from reaching visible surface layers.*

Stage 4 - Acceleration: LHA gently exfoliates to accelerate the removal of pigmented cells already present.

This comprehensive approach explains why the formula delivers such dramatic results—it's not relying on a single mechanism but targeting hyperpigmentation from multiple angles simultaneously.

Clinical Results for Proven Transformation

Testing on 70 women across phototypes I-VI delivered an impressive transformation:*

After 7 Days: Visible results in triple efficacy—improvements are visible in dark spots, wrinkles, and dullness. Skin appears noticeably brighter and more radiant.

After 8 Weeks: 86% reduction in dark spots (clinically proven).* Wrinkles visibly reduced. Radiance dramatically improved across all participants.

Consumer Experience: 97% felt their skin was comfortable all day long. 94% received compliments from others who spontaneously noticed their improved skin, the kind of visible transformation that gets noticed.* (testimonies and pictures were notary-certified)

A Revolutionary Texture

The "creamy-serum" designation isn't just marketing; it describes a genuinely innovative texture that absorbs like a serum while providing the comfort of a cream. This highly moisturizing and sensorial texture is fast-penetrating and ultra-caring, delivering both immediate comfort and long-term results with a powdery finish.* 97% of users agreed it was the ideal texture.*

Addressing Multiple Concerns Simultaneously

One of the most impressive aspects of Revitalift Laser Melasyl Creamy-Serum is its ability to work on premature aging signs simultaneously: dark spots, wrinkles, and dull tone.* This makes it the perfect solution for anyone experiencing multiple skin concerns—you don't need separate treatments for brightening versus anti-aging. The formula addresses both with clinical-grade efficacy.

How to Use: Apply morning and night to a cleansed face and neck. Press gently into skin and allow 30-60 seconds for absorption before layering additional products. For optimal results, follow with SPF in the morning—daily sun protection is essential to prevent new dark spots while Melasyl™ corrects existing ones.

Rigorous Safety Testing

Melasyl™ has been tested with alternative methods such as the Episkin reconstructed skin model developed by L'Oréal—a pioneering validated model developed and validated in the 1970's as part of L'Oréal's commitment to beauty with no animal testing.* This ensures safety and tolerance across diverse skin types without animal testing since 1989.

Our products are safe for everyone, but during pregnancy, as hormones vary a lot, the sensitivity may vary. That's why L'Oréal advises consulting a doctor.

Environmental Responsibility

From an environmental perspective, Melasyl™ was selected not just for its efficacy but also for its responsible water footprint and overall low environmental impact.* The development process demonstrated a thoughtful compromise between efficacy, safety, bioavailability, and environmental considerations—proving that breakthrough innovation can also be responsible.*

Melasyl™'s unique mechanism makes it effective against multiple types of hyperpigmentation, each triggered by different factors but sharing the same melanin overproduction pathway.

1. Sun-Induced Hyperpigmentation

UV radiation, even without visible sun exposure, triggers melanocytes to produce melanin as a defense mechanism. Years of cumulative exposure result in sun spots and age spots on chronically exposed areas like the face, hands, and shoulders. Melasyl™ prevents UV-induced immediate skin darkening and inhibits delayed tanning,* making it an essential partner to daily UV protection.

2. Hormonal Pigmentation (Melasma)

Hormonal changes from pregnancy, birth control, or hormone replacement therapy trigger melanocyte activity, causing stubborn symmetrical patches across the face. While melasma is notoriously difficult to treat, Melasyl™'s mechanism of intercepting precursors works regardless of the hormonal trigger, offering hope for this challenging condition.*

3. Age Spots

As skin ages, melanocyte function becomes dysregulated while cell turnover slows dramatically. Decades of cumulative sun exposure compound aging's effects. Melasyl™ addresses both the overproduction of melanin and, through its formulation with exfoliating actives like LHA, helps accelerate the shedding of pigmented cells that have accumulated over time.

4. Post-Inflammatory Hyperpigmentation (PIH)

PIH results from skin inflammation—like acne breakouts and scars, insect bites, burns, eczema flare-ups, or aggressive treatments. When skin experiences inflammation and irritation, it releases chemical messengers that urge melanocytes to produce excess melanin. Melasyl™ intercepts these melanin precursors regardless of what triggered their production, making it particularly effective for post-acne marks.*

Melasyl™'s development reflects L'Oréal's commitment to both human safety and environmental responsibility.

Rigorous Safety Testing

Melasyl™ has been tested with alternative methods such as the Episkin reconstructed skin model developed by L'Oréal—a pioneering validated model developed and validated in the 1970's as part of L'Oréal's commitment to beauty with no animal testing.* This ensures safety and tolerance across diverse skin types without animal testing since 1989.

Our products are safe for everyone, but during pregnancy, as hormones vary a lot, the sensitivity may vary. That's why L'Oréal advises consulting a doctor.

Environmental Responsibility

From an environmental perspective, Melasyl™ was selected not just for its efficacy but also for its responsible water footprint and overall low environmental impact.* The development process demonstrated a thoughtful compromise between efficacy, safety, bioavailability, and environmental considerations—proving that breakthrough innovation can also be responsible.*

Melasyl™'s unique mechanism makes it effective against multiple types of hyperpigmentation, each triggered by different factors but sharing the same melanin overproduction pathway.

1. Sun-Induced Hyperpigmentation

UV radiation, even without visible sun exposure, triggers melanocytes to produce melanin as a defense mechanism. Years of cumulative exposure result in sun spots and age spots on chronically exposed areas like the face, hands, and shoulders. Melasyl™ prevents UV-induced immediate skin darkening and inhibits delayed tanning,* making it an essential partner to daily UV protection.

2. Hormonal Pigmentation (Melasma)

Hormonal changes from pregnancy, birth control, or hormone replacement therapy trigger melanocyte activity, causing stubborn symmetrical patches across the face. While melasma is notoriously difficult to treat, Melasyl™'s mechanism of intercepting precursors works regardless of the hormonal trigger, offering hope for this challenging condition.*

3. Age Spots

As skin ages, melanocyte function becomes dysregulated while cell turnover slows dramatically. Decades of cumulative sun exposure compound aging's effects. Melasyl™ addresses both the overproduction of melanin and, through its formulation with exfoliating actives like LHA, helps accelerate the shedding of pigmented cells that have accumulated over time.

4. Post-Inflammatory Hyperpigmentation (PIH)

PIH results from skin inflammation—like acne breakouts and scars, insect bites, burns, eczema flare-ups, or aggressive treatments. When skin experiences inflammation and irritation, it releases chemical messengers that urge melanocytes to produce excess melanin. Melasyl™ intercepts these melanin precursors regardless of what triggered their production, making it particularly effective for post-acne marks.*

The Power of Synergistic Ingredients

L'Oréal Paris often combines Melasyl™ with other well-known active ingredients, such as niacinamide, creating a synergistic effect that enhances overall efficacy in reducing dark spots and improving skin tone uniformity.*

This strategic combination isn't accidental—it's based on understanding how different mechanisms work together. Niacinamide further aids in regulating melanin overproduction and transfer, creating complementary action with Melasyl™'s precursor interception.*

The Non-Negotiable: Daily UV Protection

It is recommended to include daily UV protection in the skincare routine to control excess pigmentation.* This isn't optional advice—it's essential for success. UV exposure is responsible for triggering or worsening virtually all pigmentation types. Without daily UV protection, you're creating new dark spots as fast as Melasyl™ corrects existing ones.

The ideal routine pairs Melasyl™ Creamy-Serum morning and night with broad-spectrum SPF 50+ every morning. This creates dual action: correction of existing spots plus prevention of new dark spot formation.

Melasyl™ represents a paradigm shift in how we approach the problem of dark spots, uneven skin tone, and hyperpigmentation. After decades of relying on tyrosinase inhibitors, this multi-patented molecule offers a fundamentally new mechanism: intercepting melanin precursors before they mark the skin.*

The numbers tell the story: 18 years of research, 100,000 molecules screened, 121 scientific studies, 23 global patents, and 86% dark spot reduction in clinical testing.* But beyond the impressive statistics lies something more meaningful—a solution that works across all skin tones, addresses multiple types of hyperpigmentation, and delivers visible results within days.

L'Oréal Paris has made this groundbreaking ingredient accessible through Revitalift Laser Melasyl Creamy-Serum, combining Melasyl™ with niacinamide and Vitamin C for comprehensive brightening that 94% of users noticed enough to receive compliments from others.* This is the kind of transformation that changes not just how your skin looks, but how you feel about your skin.

Your journey to visibly brighter, more even-toned skin starts with understanding that not all brightening ingredients are created equal. Melasyl™ isn't just another active in a long list—it's a breakthrough nearly two decades in the making, representing the cutting edge of pigmentation science made accessible for everyday use. 

References

• De Dormael, R., Sextius, P., Bourokba, N., Mainguene, E., Tachon, R., Kumar, G., Jouni, H., ... & Diridollou, S. (2024). 2-MERCAPTONICOTINOYL GLYCINE, A NEW MOLECULE THAT PREVENTS AND DECREASES UV-INDUCED PIGMENTATION. 25th World Congress of Dermatology (WCD) 2023. [Scientific Poster]
•  Prévot-Guéguiniat, A., Sextius, P., Lereaux, G., Warrick, E., Ben Hassine, S., Baux, L., ... & Marat, X. (2024). DISCOVERY OF 2-MERCAPTONICOTINOYL GLYCINE: A NEW POTENT BRIGHTENING AGENT FOR HYPERPIGMENTATION MANAGEMENT, EXHIBITING A LOW ENVIRONMENTAL IMPACT. 25th World Congress of Dermatology (WCD) 2023. [Scientific Poster]
• Sextius, P., De Dormael, R., Prévot Guéguiniat, A., Lereaux, G., Warrick, E., & Diridollou, S. (2024). 2-MERCAPTONICOTINOYL GLYCINE, A POTENT BRIGHTENING AGENT EXHIBITING A UNIQUE MODE OF ACTION INVESTIGATED IN VITRO & IN VIVO. 25th World Congress of Dermatology (WCD) 2023. [Scientific Poster]
• L'Oréal Paris. (n.d.). The Science Behind Melasyl™: Our Strongest Brightening Active Ever. [Scientific Dossier]
• Prevot-Gueguiniat, A., Sextius, P., Lereaux, G., Tachon, R., Mainguene, E., Tricaud, C., Diridollou, S., & Marat, X. (2024). Discovery of 2-mercaptonicotinoyl glycine, a new potent brightening agent for hyperpigmentation management. International Journal of Cosmetic Science, 46(2), 241-249. doi: 10.1111/ics.12933. [PubMed: 38433524]
• De Dormael, R., Sextius, P., Bourokba, N., Mainguene, E., Tachon, R., Kumar, G., Jouni, H., & Diridollou, S. (2024). 2-mercaptonicotinoyl glycine prevents UV-induced skin darkening and delayed tanning. International Journal of Cosmetic Science, 46(2), 250-258. doi: 10.1111/ics.12932. [PubMed: 38560773]
• L'Oréal Groupe Press Release, "L'Oréal Groupe Launches Melasyl™, A Groundbreaking Ingredient to Address Localized Skin Pigmentation Issues," March 11, 2024.